Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP1 | P24666 | 6/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 4/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.42 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.40 |
| ▸ | HTR3A | P46098 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8399990 | 0.93 | ACP1 (0.50) | ACP1KCNH2HRH3ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL8399939 | 0.92 | ACP1 (0.49) | ACP1KCNH2HRH3ESR1ESR2 | |
| SCHEMBL8401754 | 0.89 | ESR1 (0.57) | ACP1ESR1ESR2 | |
| SCHEMBL8403605 | 0.89 | ESR1 (0.50) | ACP1HRH3ESR1ESR2SMARCA2 | |
| SCHEMBL8399895 | 0.88 | ESR1 (0.55) | ACP1ESR1ESR2 | |
| SCHEMBL7935036 | 0.87 | ESR1 (0.48) | ACP1ESR1ESR2BACE1 | |
| SCHEMBL8399933 | 0.82 | ESR1 (0.54) | ACP1HRH3ESR1ESR2SMARCA2 | |
| SCHEMBL8403331 | 0.81 | ESR1 (0.60) | ACP1ESR1ESR2SMARCA2BACE1 | |
| SCHEMBL8405721 | 0.81 | ESR1 (0.56) | ACP1ESR1ESR2 | |
| SCHEMBL8519430 | 0.80 | ESR1 (0.59) | ACP1ESR1ESR2SMARCA2BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5929090-A | NOVEL COMPOUNDS FOR TREATING ESTROGEN DEPRIVATION CAUSED BY MENOPAUSE OR OVARIECTOMY; TREATING OSTEOPOROSIS, CARDIOVASCULAR DISEASES, AND ENDOMETRIOSIS | ELI LILLY AND COMPANY (US) | 1999-07-27 | — | — | US | disclosed |